Biologics, biosimilars and PBS sustainability graph data
Accessible versions of the data
Figure 1a: Changes to ex-manufacturer price of etanercept PBS listing
| Date | Etanercept price |
| 1/04/2012 | $1,630 |
| 1/04/2013 | $1,630 |
| 1/04/2014 | $1,630 |
| 1/04/2015 | $1,630 |
| 1/04/2016 | PBS 5% price reduction $1,549 |
| 1/04/2017 | Biosimilar listed – 40% price reduction $939 |
| 1/04/2018 | $939 |
| 1/04/2019 | $939 |
| 1/04/2020 | $939 |
| 1/04/2021 | $939 |
Return to Medicinewise News: Biologics, biosimilars and PBS sustainability
Figure 1b: Changes to ex-manufacturer price of infliximab PBS listing
| Date | Infliximab price |
| 31/5/2012 | $752 |
| 1/10/2012 | $752 |
| 1/10/2013 | $752 |
| 1/10/2014 | $752 |
| 1/10/2015 | $752 |
| 1/12/2015 | Biosimilar listed – 23% price reduction $575 |
| 1/10/2016 | $575 |
| 1/10/2017 | $507 |
| 1/10/2018 | Price disclosure $449 |
| 1/10/2019 | $321 |
| 1/10/2020 | $321 |
| 1/04/2021 | $321 |
Return to Medicinewise News: Biologics, biosimilars and PBS sustainability